Methods of identifying and treating patients with HIF-2 inhibitor resistance
Abstract:
The present disclosure provides methods of identifying patients who have partial or total resistance to HIF-2 inhibitors or who develop partial or total resistance to HIF-2 inhibitors after treatment and providing suitable treatment to these patients.
Information query
Patent Agency Ranking
0/0